Resminostat

製品コードS2693 バッチS269301

印刷

化学情報

Synonyms

RAS2410

Storage
(From the date of receipt)

3 years -20°C powder
1 years -80°C in solvent

化学式

C₁₆H₁₉N₃O₄S

分子量

349.4

CAS No.

864814-88-0

Solubility (25°C)*

体外

DMSO

70 mg/mL (200.34 mM)

Ethanol

70 mg/mL (200.34 mM)

Water

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。	3.000mg/ml (8.59mM)	Taking the 1 mL working solution as an example, add 50 μL of 60 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Clear solution	5% DMSO 1 95% Corn oil この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。	0.875mg/ml (2.50mM)	Taking the 1 mL working solution as an example, add 50 μL of 17.5 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	Resminostat (RAS2410) dose-dependently and selectively inhibits HDAC1/3/6 with IC50 of 42.5 nM/50.1 nM/71.8 nM, less potent to HDAC8 with IC50 of 877 nM.
in vitro	Resminostat [HCl] is acting as a potent inhibitor of recombinant HDAC 1, 3 and 6 isoenzymes with a substrate competitive binding mode. It can induce hyperacetylation of histone H4 in MM cells. Low micromolar concentrations of this compound abrogates cell growth and strongly induces apoptosis in MM cell lines (OPM-2, NCI-H929, U266 ) as well as primary MM cells. At 1 μM, this chemical inhibits proliferation and induces G0/G1 cell cycle arrest in OPM-2, NCI-H929, U266 MM cell lines accompanied with decreased levels of cyclin D1, cdc25a, Cdk4 and pRb as well as upregulation of p21. This compound decreases phosphorylation of 4E-BP1 and p70S6k indicating an interference with Akt pathway signalling. Treatment with this agent results in increased protein levels of Bim and Bax and decreases levels of Bcl-xL. Caspases 3, 8 and 9 are activated by it. Furthermore, synergistic effects are observed for combinations of this compound with melphalan and the proteasome inhibitors bortezomib and S-2209. ^[1]
in vivo	Oral resminostat at 600 mg QD continuously d1−5 in a 14 day cycle is well-tolerated. This compound shows a favourable PK profile, with high bioavailability and low inter-pt variability. The apparent t _1/2 of this compound ranged from 2.7 to 4.4 hours. The modulation of plasma biomarkers further indicates drug activity. ^[2]

プロトコル(参考用のみ)

キナーゼアッセイ	Enzymatic HDAC activity assays
キナーゼアッセイ	Forty microliter enzyme buffer (15 mM Tris HCl pH 8.1, 0.25 mM EDTA, 250 mM NaCl, 10% v:v glycerol) containing HDAC1, 3, 6 or 8 activity, 29 μL enzyme buffer and 1 μL resminostat [HCl] at different concentrations are added to a 96-well microtitre plate and the reaction started by the addition of 30μL substrate peptide Ac-NH-GGK(Ac)-AMC (HDAC1, 3 and 6 assays, final concentrations 6 μM for HDAC1, 10μM for HDAC6 and 25μM for HDAC3/DAD) or Ac-RHK(Ac)K(Ac)-AMC (HDAC8 assay, final concentration 50 μM). After incubation for 180 min (HDAC1, HDAC6, HDAC8) or 120 min (HDAC3) at 30°C, the reaction is terminated by the addition of 25 μL stop solution (50 mM Tris HCl pH 8, 100 mM NaCl, 0.5 mg/ml trypsin and 2 μM trichostatin A [TSA]). After incubation at room temperature for further 40 min, fluorescence is measured using a multilabel counter (extinction 355 nm, emission 460 nm) for quantification of AMC generated by tryptic cleavage of the deacetylated peptide. For the calculation of the 50% inhibitory concentration (IC50) values the fluorescence in wells without test compound (1% DMSO, negative control) is set as 100% enzymatic activity and the fluorescence in wells with 2 μM TSA (positive control) are set at 0% enzymatic activity (background fluorescence substracted).
細胞アッセイ	細胞株	OPM-2, NCI-H929, RPMI-8226 and U266
	濃度	~ 10 μM
	反応時間	48, 96 h
	実験の流れ	WST-1 assay was used to determine the cell viability of HCC cells treated with Resminostat (4SC-202). The results showed that this compound inhibited cell growth in a dose-dependent manner. Additionally, this chemical induced apoptosis in HCC cells. The effect of this compound on cell cycle distribution was also examined. It was found that this chemical caused G1 phase arrest. Furthermore, this compound suppressed the migration and invasion of HCC cells. The study suggests that this chemical may be a potential therapeutic agent for HCC.

参考

https://pubmed.ncbi.nlm.nih.gov/20201941/
http://www.ejcancersupplements.com/article/S1359-6349%2808%2972327-9

カスタマーフィードバック

: Data from [Data independently produced by , , Head Neck, 2017, 39(5):900-907]

: Data from [Data independently produced by , , Head Neck, 2017, 39(5):900-907.]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

R406 and its structural analogs reduce SNCA/α-synuclein levels via autophagic degradation [ Autophagy, 2025, 1-17.]	PubMed: 40143425
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment. [ J Cancer, 2020, 6;11(14):4059-4072]	PubMed: 32368288
Selective Inhibition of HDAC6 Sensitizes Cutaneous T-cell Lymphoma to PI3K Inhibitors [ Oncol Lett, 2020, 20(1):533-540]	PubMed: 32565979
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6 [ Biochemistry, 2019, 58(49):4912-4924]	PubMed: 31755702
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer [ Cancer Res, 2018, 78(20):5731-5740]	PubMed: 30135193
Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling [Lucas J, et al. Int J Oncol, 2018, 53(4):1469-1480]	PubMed: 30066852
Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines [Enzenhofer E, et al. Head Neck, 2017, 39(5):900-907]	PubMed: 28170128
Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study. [ Sci Rep, 2016, 6:38407]	PubMed: 27910927

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。